Real-World Evidence Associated With a First-Generation BTK Inhibitor in Patients With CLL/SLL
The Value of Colonoscopic Colorectal Cancer Screening of Adults Aged 50 to 64
Screening commercially insured individuals for colorectal cancer is a high-value service, costing less per year of life saved than breast or cervical cancer screening.